Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corifollitropin alfa double ovarian stimulation versus two conventional stimulation cycles in poor ovarian responders undergoing IVF
2018-003484-56Phase 4Active
- Sponsor
- Miguel Caballero Campo
- Start
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of corifollitropin alfa in female infertility and poor ovarian response (POR) (2 arms), sponsored by Miguel Caballero Campo. Primary endpoint: Number of total retrieved oocytes. Started Jul 2019; status: active.
02
Drugs
corifollitropin alfa
03
Conditions
female infertilitypoor ovarian response (POR)
Beyond the preview
Go deeper on 2018-003484-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003484-56.